SIRT6 and prostate carcinoma: The protein level of SIRT6 was slightly higher in aggressive prostate cell lines (PC3M and C42B) compared with the parental cell lines (PC3 and LNCap) (Figure S3A), indicating SIRT6 may affect metastatic phenotype of prostate cancer cells.